Treatment Uptake and Availability of Antimalarial Drugs for Intermittent Preventative Treatment in Pregnant Women in Malawi

Loren Bausell and Katherine Wolf
USAID DELIVER PROJECT, Task Order 7; June, 2015

40 pp. 1.4 MB
http://deliver.jsi.com/dlvr_content/resources/allpubs/countryreports/MW_TreaUptaAv
ai.pdf
Pic 001_resize

Throughout Africa, 30 million pregnant women are exposed to malaria each year. Malaria in pregnancy carries increased risk of low birth weight, severe maternal anaemia, maternal mortality, miscarriage, premature delivery, and stillbirth. To address malaria during pregnancy, the Roll Back Malaria Consortium advocates a three-pronged approach, one aspect of which is the delivery of intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP). The report looks at Malawi to analyze the relationship between SP stockout rates and coverage of SP for intermittent preventative treatment of malaria in pregnant women. This analysis was performed to explore the relationship between stock availability and intervention coverage.

(Visited 38 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria, Maternal & Child Health. Bookmark the permalink.